NCT02835612 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Guinsburg R, de Almeida MF, de Castro JS, Silveira RC, Caldas JP, Fiori HH, do Vale MS, Abdallah VO, Cardoso LE, Alves Filho N, Moreira ME, Acquesta AL, Ferrari LS, Bentlin MR, Venzon PS, Gonçalves Ferri WA, Meneses Jdo A, Diniz EM, Zanardi DM, Dos Santos CN, Bandeira Duarte JL, Rego MA
Death or survival with major morbidity in VLBW infants born at Brazilian neonatal research network centers. J Matern Fetal Neonatal Med. 2016 Mar;29(6):1005-9. doi: 10.3109/14767058.2015.1031740. Epub 2015 Apr 2.
Procianoy RS, Mendes EW, Silveira RC
Massage therapy improves neurodevelopment outcome at two years corrected age for very low birth weight infants. Early Hum Dev. 2010 Jan;86(1):7-11. doi: 10.1016/j.earlhumdev.2009.12.001. Epub 2009 Dec 22.
Silveira RC, Filipouski GR, Goldstein DJ, O'Shea TM, Procianoy RS
Agreement between Bayley Scales second and third edition assessments of very low-birth-weight infants. Arch Pediatr Adolesc Med. 2012 Nov;166(11):1075-6. doi: 10.1001/archpediatrics.2012.7

Early Intervention Program for Preterm Infants and Their Parents: Establishing the Impact at 18 Months Corrected Age

Clinical trial NCT02835612 - References